Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is -28.26% vs -34.75% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 10.00% vs -900.00% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 20.69% vs -193.55% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 0.00% vs -100.00% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
Compare Quarterly Results Of Norris Medicines With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -28.26% vs -34.75% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -67.00% vs 57.48% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 10.00% vs -900.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 50.00% vs -100.00% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 20.69% vs -193.55% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 53.06% vs -226.67% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 0.00% vs -100.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -81.82% vs 37.50% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025